Last reviewed · How we verify

NCT04819165: COVIACS

Healthcare-associated Infections in Severe COVID-19 During 2020

Completed Last updated 26 March 2021
What this trial tests

trial testing COVID-19 in Respiration, Artificial in 252 participants. Completed in 31 January 2021.

Timeline
1 March 2020
Primary endpoint
31 December 2020
31 January 2021

Quick facts

Lead sponsorSanatorio Anchorena San Martin
StatusCompleted
Study typeOBSERVATIONAL
Enrollment252
Start date1 March 2020
Primary completion31 December 2020
Estimated completion31 January 2021
Sites1 location across Argentina

Drugs / interventions tested

Conditions studied

Sponsor

Sanatorio Anchorena San Martin

Who can join

18 and older, any sex, with Respiration, Artificial or COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In patients who develop ARDS due to SARS-CoV-2 (CARDS), a longer duration of invasive mechanical ventilation (IMV) and ICU stay has been reported compared to ARDS not associated with SARS-CoV-2. Consequently, the days of stay in ICU increase Identifying the risk factors associated with the development of this complication and developing measures aimed at its prevention could have a favorable impact on the clinical course of seriously ill patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of COVID-19

Trials testing the same drug.

Other recruiting trials for Respiration, Artificial

Currently open trials in the same condition.

Other Sanatorio Anchorena San Martin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04819165.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing